Structures by: Haoudi A.
Total: 28
1,1'-(Hexane-1,6-diyl)bis(indoline-2,3-dione)
C22H20N2O4
IUCrData (2016) 1, 4 x160542
a=15.1498(3)Å b=7.4949(2)Å c=16.4795(3)Å
α=90° β=90° γ=90°
1-[(2<i>E</i>)-3-Phenylprop-2-en-1-yl]-1<i>H</i>-indole-2,3-dione
C17H13NO2
IUCrData (2016) 1, 4 x160633
a=8.2585(2)Å b=7.26770(10)Å c=44.4667(8)Å
α=90° β=90° γ=90°
1-(3-Bromopropyl)indoline-2,3-dione
C11H10BrNO2
IUCrData (2016) 1, 4 x160593
a=7.7113(2)Å b=8.1375(2)Å c=17.8089(4)Å
α=90° β=93.8300(13)° γ=90°
1-Propyl-1<i>H</i>-indole-2,3-dione
C11H11NO2
IUCrData (2016) 1, 4 x160609
a=4.4666(2)Å b=12.9169(6)Å c=16.3857(8)Å
α=90° β=90° γ=90°
5-Fluoro-1-(prop-2-en-1-yl)-2,3-dihydro-1<i>H</i>-indole-2,3-dione
C11H8FNO2
IUCrData (2017) 2, 1 x170028
a=31.531(3)Å b=4.2752(4)Å c=14.1080(13)Å
α=90° β=90° γ=90°
5-Bromo-1-nonylindoline-2,3-dione
C17H22BrNO2
IUCrData (2016) 1, 5 x160791
a=4.8428(2)Å b=31.7181(14)Å c=10.7171(5)Å
α=90° β=101.206(2)° γ=90°
1-Allyl-5-chloroindoline-2,3-dione
C11H8ClNO2
IUCrData (2016) 1, 6 x160862
a=31.2222(6)Å b=7.9107(2)Å c=8.3373(2)Å
α=90° β=90° γ=90°
5-Bromo-1-(6-bromohexyl)indoline-2,3-dione
C14H15Br2NO2
IUCrData (2016) 1, 6 x160883
a=4.6344(2)Å b=12.6284(6)Å c=25.3537(12)Å
α=90° β=90° γ=90°
1-Benzyl-5-chloroindoline-2,3-dione
C15H10ClNO2
IUCrData (2016) 1, 6 x160854
a=4.4576(2)Å b=27.6646(11)Å c=20.9530(8)Å
α=90° β=93.870(2)° γ=90°
5-Bromo-1-methylindoline-2,3-dione
C9H6BrNO2
IUCrData (2016) 1, 5 x160792
a=4.06340(10)Å b=11.9235(3)Å c=18.0978(5)Å
α=90° β=96.170(2)° γ=90°
5-Chloro-1-methylindoline-2,3-dione
C9H6ClNO2
IUCrData (2016) 1, 6 x160913
a=3.9766(4)Å b=11.9503(13)Å c=17.947(2)Å
α=90° β=96.163(3)° γ=90°
5-Fluoro-1-[(1-{[(1<i>S</i>,2<i>R</i>,6<i>R</i>,8<i>S</i>,9<i>R</i>)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0^2,6^]dodecan-8-yl]methyl}-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-2,3-dihydro-1<i>H</i>-indole-2,3-dione
C23H25FN4O7
IUCrData (2017) 2, 5 x170739
a=11.1688(2)Å b=9.0576(2)Å c=11.9237(2)Å
α=90° β=106.7700(10)° γ=90°
1-[(1-{[(1<i>S</i>,2<i>R</i>,6<i>R</i>,8<i>R</i>,9<i>S</i>)-4,4,11,11-Tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0^2,6^]dodecan-8-yl]methyl}-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-2,3-dihydro-1<i>H</i>-indole-2,3-dione
C23H26N4O7
IUCrData (2017) 2, 5 x170670
a=25.6622(8)Å b=8.7731(3)Å c=10.3928(3)Å
α=90° β=101.8470(10)° γ=90°
1-(12-Bromododecyl)-5-chloroindoline-2,3-dione
C20H27BrClNO2
IUCrData (2016) 1, 6 x160971
a=8.0353(4)Å b=8.3496(5)Å c=17.1096(11)Å
α=84.491(3)° β=78.086(3)° γ=65.126(2)°
NA8
C15H14N2O2
Acta Crystallographica Section E Crystallographic Communications (2020) 76, 4 467
a=8.4959(2)Å b=9.6479(2)Å c=8.7619(2)Å
α=90° β=116.9210(10)° γ=90°
4-Allyl-6-bromo-2-(4-chlorophenyl)-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C15H11BrClN3
Acta Crystallographica Section E (2019) 75, 1 43-48
a=7.6218(5)Å b=8.5238(5)Å c=11.1093(7)Å
α=95.739(3)° β=98.880(3)° γ=94.979(3)°
5,5-Diphenyl-1,3-bis(prop-2-yn-1-yl)imidazolidine-2,4-dione
C21H16N2O2
Acta Crystallographica Section E (2019) 75, 7 951-956
a=10.144(3)Å b=7.952(2)Å c=10.928(3)Å
α=90° β=97.104(12)° γ=90°
5-Bromo-1-{2-[2-(2-chloroethoxy)ethoxy]ethyl}indoline-2,3-dione
C14H15BrClNO4
Acta Crystallographica Section E (2019) 75, 9 1372-1378
a=12.4682(4)Å b=14.6397(5)Å c=8.3524(3)Å
α=90° β=91.392(2)° γ=90°
5-Bromo-1-ethylindoline-2,3-dione
C10H8BrNO2
Acta Crystallographica Section E (2015) 71, 12 o1024-o1025
a=9.5198(3)Å b=10.0655(3)Å c=11.2341(3)Å
α=70.9288(16)° β=75.4109(16)° γ=85.2199(16)°
6-Bromo-1-(1,2-propadienyl)-3-(2-propynyl)-1<i>H</i>- imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C12H8BrN3O
Acta Crystallographica Section E (2010) 66, 4 o755
a=9.6369(4)Å b=9.3086(4)Å c=13.5481(5)Å
α=90.00° β=99.123(2)° γ=90.00°
6-Bromo-1,3-di-2-propynyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin- 2(3<i>H</i>)-one
C12H8BrN3O
Acta Crystallographica Section E (2010) 66, 4 o756
a=9.0725(3)Å b=18.6212(5)Å c=7.0684(2)Å
α=90.00° β=102.9950(10)° γ=90.00°
Diethyl 2,6,11-trioxo-2,3-dihydro-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-1,3-diacetate
C23H20N2O7
Acta Crystallographica Section E (2011) 67, 8 o2081
a=17.4620(10)Å b=13.0646(9)Å c=9.1411(6)Å
α=90.00° β=103.915(3)° γ=90.00°
1-Allyl-3-benzyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C17H16N2O
Acta Crystallographica Section E (2013) 69, 9 o1477-o1478
a=9.0667(2)Å b=9.3922(2)Å c=9.6486(2)Å
α=94.2180(10)° β=113.5430(10)° γ=106.2650(10)°
3-Allyl-1-{[3-(4-nitrophenyl)-4,5-dihydro-1,3-oxazol-5-yl]methyl}-1<i>H</i>- anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione
C28H20N4O6
Acta Crystallographica Section E (2011) 67, 6 o1363-o1364
a=10.0780(3)Å b=22.7094(6)Å c=11.2729(3)Å
α=90.00° β=113.8090(10)° γ=90.00°
3-Benzyl-6-bromo-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C13H10BrN3O
Acta Crystallographica Section E (2013) 69, 6 o962
a=4.2399(2)Å b=10.4463(4)Å c=14.5144(6)Å
α=107.611(2)° β=90.628(3)° γ=99.784(3)°
1,3-Bis(prop-2-yn-1-yl)-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione
C21H12N2O3
Acta Crystallographica Section E (2013) 69, 6 o944
a=16.6972(5)Å b=4.56020(10)Å c=21.2500(5)Å
α=90.00° β=96.352(2)° γ=90.00°
6-Bromo-1,3-bis[(1,3-dioxolan-2-yl)methyl]-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one
C14H16BrN3O5
Acta Crystallographica Section E (2013) 69, 7 o1029-o1030
a=5.11440(10)Å b=17.8029(4)Å c=16.5365(5)Å
α=90.00° β=97.009(2)° γ=90.00°
3-Benzyl-1-{[3-(4-chlorophenyl)isoxazol-5-yl]methyl}-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C24H18ClN3O2
Acta Crystallographica Section E (2013) 69, 9 o1451
a=8.5427(2)Å b=9.8290(2)Å c=13.2658(3)Å
α=81.1330(10)° β=78.7630(10)° γ=64.3430(10)°